<DOC>
	<DOCNO>NCT01551056</DOCNO>
	<brief_summary>The purpose study evaluate onset duration action AC-170 0.24 % compare vehicle prevention sign symptom allergic conjunctivitis conjunctival allergen challenge ( CAC ) model .</brief_summary>
	<brief_title>A Multi-Center Study Evaluating Onset Duration Action AC-170 0.24 % Compared Vehicle Conjunctival Allergen Challenge ( CAC )</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>positive bilateral conjunctival allergen challenge ( CAC ) reaction know contraindication sensitivity study medication component ocular condition , opinion investigator , could affect subject safety trial parameter use disallowed medication period indicate prior enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>